Pharmaceutical compositions for the treatment of cftr-mediated disorders
US-2015080431-A1 · Mar 19, 2015 · US
Modulators of ATP-binding cassette transporters
US10662192B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10662192-B2 |
| Application number | US-201816006105-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 12, 2018 |
| Priority date | Jun 24, 2004 |
| Publication date | May 26, 2020 |
| Grant date | May 26, 2020 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator, compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.
First claim
Opening claim text (preview).
What is claimed is: 1. A compound having the formula: 2. A pharmaceutically acceptable salt of a compound having the formula:
Assignees
Inventors
Classifications
Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals · CPC title
for myasthenia gravis · CPC title
- C07D209/08Primary
with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring · CPC title
of the same non-condensed six-membered aromatic ring · CPC title
Preparation of compounds containing amino groups bound to a carbon skeleton · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10662192B2 cover?
- The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator, compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.
- Who is the assignee on this patent?
- Vertex Pharma
- What technology area does this patent fall under?
- Primary CPC classification C07D209/08. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue May 26 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).